Blog
Protecting Innovation in an AI-Powered Age: Patents
Read moreMore Is More: Ensure Your Mark Is Protectable Before You Enforce
Can Clinical Trials Negate Patentability for Pharma Inventions?
PTAB Issues FAQs on Interim Process for Workload Management
Federal Circuit Finds Beer Trademark Application Nothing but "Chicken Scratch"
Munich Appeals Court Reinforces Security-Centric FRAND Framework in SEP Dispute
Trump’s Drug Price Executive Order: What Drugmakers Should Know
Key Insights From the UPC’s First SEP Decision
TTAB Puts Pool Hall Behind the Eight Ball
Trademark Owners May Play Only Zone Defense at the TTAB
What to Know About the PTAB’s Discretionary Denial Shakeups
Analyzing SEPs: Strategies to Avoid or Prepare for Litigation
The Outlook for SEPs in 2025: Anti-Suit Injunctions, DOJ Policy, and GenAI